Correspondence 0001104659-23-112548 from AVENUE THERAPEUTICS, INC. (ATXI) (CIK 0001644963) (ATXI)
AVENUE THERAPEUTICS, INC. (ATXI) (CIK 0001644963)
Date: Oct. 30, 2023 · CIK: 0001644963 · Accession: 0001104659-23-112548
AI Filing Summary & Sentiment
File numbers found in text: 333-274562
Letter
Re: Avenue Therapeutics, Inc.
October 30, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-1004
Registration Statement on Form S-1, as amended
File No. 333-274562
Ladies and Gentlemen:
As the placement agent of the proposed offering of Avenue Therapeutics, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 9:00 a.m., Eastern Time, on Tuesday, October 31, 2023, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through October 30, 2023, we distributed to each dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as “E-red” copies of the Preliminary Prospectus dated October 23, 2023, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Maxim Group LLC
Show Raw Text
CORRESP
1
filename1.htm
October 30, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-1004
Re:
Avenue Therapeutics, Inc.
Registration Statement on Form S-1, as amended
File No. 333-274562
Ladies and Gentlemen:
As the placement agent of
the proposed offering of Avenue Therapeutics, Inc. (the “Company”), we hereby
join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 9:00 a.m.,
Eastern Time, on Tuesday, October 31, 2023, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the
General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to
advise you that, through October 30, 2023, we distributed to each dealer, who is reasonably anticipated to be invited to participate in
the distribution of the security, as many copies, as well as “E-red” copies of the Preliminary Prospectus dated October 23,
2023, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advise that
they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Maxim Group LLC
By:
/s/
Clifford A. Teller
Name:
Clifford A.
Teller
Title:
Co-President